1. Stats
  2. USPTO
  3. TC 1600
  4. Group 1610
  5. Art Unit 1618
  6. Examiner Samala

Examiner Samala Jagadishwar R

1618-SAMALA-JAGADISHWAR-R

Employment Information

Art Unit:1618 — Drug, bio-affecting and body treating compositions
Group:1610 — Pharmaceutical and Agricultural Compositions; Plant Growth Regulating Compositions: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs; In vivo Diagnostic Agents
Classes: 424 — Drug, bio-affecting and body treating compositions
376 — Induced nuclear reactions: processes, systems, and elements
514 — Drug, bio-affecting and body treating compositions
600 — Surgery
435 — Chemistry: molecular biology and microbiology
422 — Chemical apparatus and process disinfecting, deodorizing, preserving, or sterilizing
534 — Organic compounds -- part of the class 532-570 series
540 — Organic compounds -- part of the class 532-570 series
427 — Coating processes
536 — Organic compounds -- part of the class 532-570 series
Phone:(571) 272-9927
Email:jagadishwar.samala@uspto.gov
Location:VA 22314
Title:Pat Examnr Org Chem
Service:20 years
Grade:GS-13

Grant Rate and Difficulty Ranking

54
3-Year Grant rate: 75% over 338 cases
Difficulty: Medium
Difficulty Percentile: 54th

With Examiner Samala, you have a 75% chance of getting an issued patent by 3 years after the first office action. Examiner Samala is a medium examiner and in the 54th percentile across all examiners (with 100th percentile most difficult).

Grant Rate

Grant Rate Timeline

Below is the grant rate timeline for Examiner Samala, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.

Comparison with Art Unit 1618

Examiner Samala's grant rate is higher than that of Art Unit 1618 and lower than that of the USPTO.

Average Office Actions Per Grant
Examiner Samala 1.1
Art Unit 1618 2.0

Interview Benefit

Grant Rate without Interview

Examiner Samala has granted 228 of 300 cases without any applicant-requested interviews for a grant rate of 76%.

Grant Rate with Interview

Examiner Samala has granted 27 of 38 cases with at least one applicant-requested interview for a grant rate of 71%.

Interview Benefit

With Examiner Samala, conducting an interview decreases your chance of getting a patent granted by 7%.

Recent Dispositions

Recent Dispositions

Number Title OA Rejections Status IFW
18084411 Biomarkers For Nanoparticle Compositions Rejection information available with a Premium Stats subscription. See our pricing. Abandoned View
18493909 Device And Cassette For Performing A Plurality Of Synthesis Processes Of Preparing A Radiopharmaceutical In Series Patented View
18655741 Composition Of Radioactive And Non-Radioactive Microparticles Patented View
17794843 Novel Gadolinium-Based Compound, Method For Producing Same, And Mri Contrast Agent Containing Same Patented View
18199311 Plastic Containers Abandoned View
17722727 Superparamagnetic Gold Nanoparticle Cluster-Protein Nanoparticle Fusion Body For Magnetic Resonance Imaging And Magnetic Thermotherapy Abandoned View
17908630 Boron Carrying Agent For Integrated Tumor Diagnosis And Treatment, And Preparation Method Therefor And Use Thereof Patented View
18175246 Long-Lived Gadolinium Based Tumor Targeted Imaging And Therapy Agents Patented View
18001384 Granzyme B Directed Imaging And Therapy Patented View
17073153 Compounds And Compositions For Targeting Macrophages And Other Mannose-Binding C-Type Lectin Receptor High Expressing Cells And Methods Of Treating And Diagnosis Using Same Abandoned View
18365555 Pharmaceutical Composition Containing Taxane Nanoaggregates And Use Thereof Patented View
18614094 Radiopharmaceutical Conjugate Compound For Diagnosis And/or Therapeutic Uses Thereof Patented View
17682695 Compounds For Use As Iron(Iii) Mri Contrast Agents Patented View
18352435 Compositions, Methods, And Systems For The Synthesis And Use Of Imaging Agents Abandoned View
18930419 Fibroblast Activation Protein Targeting Peptides Patented View
17810956 Radiotherapeutic And Companion Imaging Agents To Target Mc1r Patented View
18932511 Novel Gene Delivery Agents Patented View
17066925 Imaging Histone Deacetylases With A Radiotracer Using Positron Emission Tomography Patented View
17864671 Functionalized Nanoparticles And Methods Of Making And Using Same Patented View
18983625 Gadolinium Chelate Compounds For Use In Magnetic Resonance Imaging Patented View
18203326 Compounds Comprising Cleavable Linker And Uses Thereof Patented View
16637192 Tunable Luminescent Organic Salts For Enhanced Imaging And Photodynamic Therapy Patented View
17622058 Prostate Specific Membrane Antigen (Psma) Ligands And Uses Thereof Abandoned View
17532083 Method Of Preparing Zirconium-89 Oxine Complex Patented View
17062757 Methods And Apparatus For Synthesizing Imaging Agents, And Intermediates Thereof Abandoned View
19184830 Purification Process For The Preparation Of Non-Carrier Added Copper-64 Patented View
18051422 Pristine Graphene Based Biosensor For Biomarker Detection And Related Core Particles, Materials Compositions Methods And Systems Patented View
16628611 Methods For Treating Tumors Abandoned View
17810316 Macrocyclic Chelators And Methods Of Use Thereof Patented View
17959278 Biogenic Hemin-Based Mri Contrast Agents, And Compositions And Methods Thereof Patented View
18063349 Liquid Vehicle For Enterography Examination Patented View
17943754 Structural Design Of A Cranial Nerve Degeneration Contrast Agent Precursors Patented View
17553113 Fibroblast Activation Protein (Fap)-Targeted Imaging And Therapy Patented View
16349445 Neutron Capture Therapy For Infection Control Of Surgical Implants Patented View
16417956 Production Of 43sc Radionuclide And Its Use In Positron Emission Tomography Abandoned View
18205751 Methods For Treating And Diagnosing Blinding Eye Diseases Patented View
19080259 Method Of Inhibiting Cancer Cell Viability Patented View
17933234 Novel Heteroaromatic Silicon-Fluoride-Acceptors Useful For 18f Labeling Of Molecules And Biomolecules, And Methods Of Preparing Same Patented View
18428591 Chemiluminescent Probes For Diagnostics And In Vivo Imaging Patented View
18161395 Psma-Targeting Ligands With Optimal Properties For Imaging And Therapy Patented View
18905806 Formulation Of Ear Drops And Methods For Delivery Thereof For Treating Upper Respiratory Infections Patented View
18745896 Purification Process For The Preparation Of Non-Carrier Added Copper-64 Patented View
17443863 Ascorbate Formulations And Methods Of Use As Contrast Agents Patented View
17492260 Compositions And Methods For Assessing Eye Vasculature Patented View
17550731 Bioorthogonal Compositions Patented View
18745906 Copper-64 Compositions And Formulations Patented View
18363369 Methods And Reagents For Tumor Targeting With Greater Efficacy And Less Toxicity Patented View
17884751 Methods Of Imaging And Delivering Therapeutic Agents Abandoned View
16469082 Nanoplasmonic Quantification Of Tumor-Derived Extracellular Vesicles In Plasma Microsamples For Detection And Treatment Monitoring Patented View
18646526 Multi-Mode Imaging Markers Patented View

Appeals Statistics

Purchase Subscription

Subscribe to Premium Examiner Statistics for unlimited access for your law firm.

Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.